UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

G.P.6.02 In vitro activities and in vivo pharmacokinetics of dual cysteine proteases inhibitors and antioxidant

Neuromuscular disorders : NMD, 2007, Vol.17 (9), p.801-801

2007

Volltextzugriff (PDF)

Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression

American journal of physiology. Regulatory, integrative and comparative physiology, 2006-06, Vol.290 (6), p.R1589-R1597

2006

Volltextzugriff (PDF)

Effects of botulinum toxin type A on digit abduction score and running wheel assays and assessment of diffusion using calcium-activated potassium channel expression

Toxicon (Oxford), 2013-06, Vol.68, p.82-82

2013

Volltextzugriff (PDF)

BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation: A Promising Neuroprotective Strategy

Proceedings of the National Academy of Sciences - PNAS, 1999-09, Vol.96 (19), p.10824-10829

1999

Volltextzugriff (PDF)

First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant

Neuromuscular disorders : NMD, 2006-04, Vol.16 (4), p.237-248

2006

Volltextzugriff (PDF)

Severe muscle dysfunction precedes collagen tissue proliferation in mdx mouse diaphragm

Journal of applied physiology (1985), 2003-05, Vol.94 (5), p.1744-1750

2003

Volltextzugriff (PDF)

Novel dual inhibitors of calpain and lipid peroxidation

Bioorganic & medicinal chemistry letters, 2004-07, Vol.14 (14), p.3825-3828

2004

Volltextzugriff (PDF)

Novel dual inhibitors of calpain and lipid peroxidation with enhanced cellular activity

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (6), p.1586-1589

2006

Volltextzugriff (PDF)

462 Minimal effective dose (MED) of onabotulinumtoxinA (onaBoNT-A) and abobotulinumtoxinA (aboBoNT-A) in a rat model of neurogenic detrusor overactivity (NDO)

European urology supplements : official journal of the European Association of Urology, 2012-02, Vol.11 (1), p.e462-e462a

2012

Volltextzugriff (PDF)

Maturation of fetal rat lung in diabetic pregnancies of graduated severity

Diabetes (New York, N.Y.), 1985-08, Vol.34 (8), p.734-743

1985

Volltextzugriff (PDF)

Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells

The Journal of immunology (1950), 1988-05, Vol.140 (10), p.3547-3552

1988

Volltextzugriff (PDF)

Effect of platelet-activating factor on in vitro and in vivo interleukin-6 production

Mediators of Inflammation, 1994, Vol.1994 (4), p.281-285

1994

Volltextzugriff (PDF)

Immunomodulatory activity of two new aza alkyl phospholipid antineoplastic drugs

Anti-cancer drugs, 1992-12, Vol.3 (6), p.599-608

1992

Volltextzugriff (PDF)

Maturation of fetal rat lung in diabetic pregnancies of graduated severity

Diabetes (New York, N.Y.), 1985-08, Vol.34 (8), p.734-743

1985

Volltextzugriff (PDF)

Inhibition of human tumor cell growth In vitro and In vivo by a specific inhibitor of human farnesyltransferase: BIM‐46068

International journal of cancer, 1999-10, Vol.83 (2), p.283-287

1999

Volltextzugriff (PDF)

Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection

Transplantation proceedings, 1988-04, Vol.20 (2 Suppl 2), p.259

1988

Volltextzugriff (PDF)

Modulation of Cytotoxic Processes by Platelet-Activating Factor

International journal of immunopathology and pharmacology, 1992-01, Vol.5 (1), p.1-11

1992

Volltextzugriff (PDF)

Prise en charge psychologique des patients « chuteurs

NPG, 2005-04, Vol.5 (26), p.32-36

2005

Volltextzugriff (PDF)

Platelet Activating Factor (PAF) Induces Human Suppressor Cell Activity

Lymphocyte Activation and Differentiation, 2019, p.621-624

Originally published 1988, 2019

Volltextzugriff (PDF)

Role of Myo-inositol in Impairment of Fetal Lung Phosphatidylglycerol Biosynthesis in the Diabetic Pregnancy: Physiological Consequences of a Phosphatidylglycerol-deficient Surfactant in the Newborn Rat

Experimental lung research, 1986, Vol.11 (3), p.195-207

1986

Volltextzugriff (PDF)

The role of platelet-activating factor (PAF) in immune and cytotoxic processes

Progress in clinical and biological research, 1989, Vol.308, p.441

1989

Volltextzugriff (PDF)

Role of flavonoids in the oxygen-free radical modulation of the immune response

Progress in clinical and biological research, 1988, Vol.280, p.173

1988

Volltextzugriff (PDF)

Effect of chronic administration of platelet-activating factor (PAF) in the guinea-pig and the rat

Advances in prostaglandin, thromboxane, and leukotriene research, 1989, Vol.19, p.371

1989

Volltextzugriff (PDF)

Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021

Biochemical and biophysical research communications, 1987-02, Vol.142 (3), p.754-760

1987

Volltextzugriff (PDF)

Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells

The Journal of immunology (1950), 1990-08, Vol.145 (3), p.980-984

1990

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

G.P.6.02 In vitro activities and in vivo pharmacokinetics of dual cysteine proteases inhibitors and antioxidant

Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression

Effects of botulinum toxin type A on digit abduction score and running wheel assays and assessment of diffusion using calcium-activated potassium channel expression

BN 80933, a Dual Inhibitor of Neuronal Nitric Oxide Synthase and Lipid Peroxidation: A Promising Neuroprotective Strategy

First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant

Severe muscle dysfunction precedes collagen tissue proliferation in mdx mouse diaphragm

Novel dual inhibitors of calpain and lipid peroxidation

Novel dual inhibitors of calpain and lipid peroxidation with enhanced cellular activity

462 Minimal effective dose (MED) of onabotulinumtoxinA (onaBoNT-A) and abobotulinumtoxinA (aboBoNT-A) in a rat model of neurogenic detrusor overactivity (NDO)

Maturation of fetal rat lung in diabetic pregnancies of graduated severity

Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells

Effect of platelet-activating factor on in vitro and in vivo interleukin-6 production

Immunomodulatory activity of two new aza alkyl phospholipid antineoplastic drugs

Maturation of fetal rat lung in diabetic pregnancies of graduated severity

Inhibition of human tumor cell growth In vitro and In vivo by a specific inhibitor of human farnesyltransferase: BIM‐46068

Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection

Modulation of Cytotoxic Processes by Platelet-Activating Factor

Prise en charge psychologique des patients « chuteurs

Platelet Activating Factor (PAF) Induces Human Suppressor Cell Activity

Role of Myo-inositol in Impairment of Fetal Lung Phosphatidylglycerol Biosynthesis in the Diabetic Pregnancy: Physiological Consequences of a Phosphatidylglycerol-deficient Surfactant in the Newborn Rat

The role of platelet-activating factor (PAF) in immune and cytotoxic processes

Role of flavonoids in the oxygen-free radical modulation of the immune response

Effect of chronic administration of platelet-activating factor (PAF) in the guinea-pig and the rat

Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021

Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells

Suchergebnisse filtern